Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Express Scripts
Daiichi Sankyo
Argus Health
Chinese Patent Office
Boehringer Ingelheim

Generated: December 15, 2017

DrugPatentWatch Database Preview

Sotalol hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for sotalol hydrochloride and what is the scope of sotalol hydrochloride patent protection?

Sotalol hydrochloride
is the generic ingredient in five branded drugs marketed by Altathera Pharms Llc, Arbor Pharms Llc, Covis Pharma Bv, Upsher-smith Labs, Apotex, Apotex Inc, Beximco Pharms Usa, Epic Pharma Inc, Impax Pharms, Mylan, Sun Pharm Industries, Teva, Vintage Pharms, and Watson Labs, and is included in twenty NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Sotalol hydrochloride has one patent family member in one country.

There are ten drug master file entries for sotalol hydrochloride. Twenty-seven suppliers are listed for this compound.

Pharmacology for sotalol hydrochloride

Drug ClassAntiarrhythmic
Mechanism of ActionAdrenergic beta-Antagonists
Physiological EffectCardiac Rhythm Alteration

Medical Subject Heading (MeSH) Categories for sotalol hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Upsher-smith LabsSOTALOL HYDROCHLORIDEsotalol hydrochlorideTABLET;ORAL075366-003May 1, 2000AB1RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaSOTALOL HYDROCHLORIDEsotalol hydrochlorideTABLET;ORAL075429-004May 1, 2000AB1RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Covis Pharma BvBETAPACE AFsotalol hydrochlorideTABLET;ORAL021151-003Feb 22, 2000AB2RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
TevaSOTALOL HYDROCHLORIDEsotalol hydrochlorideTABLET;ORAL076883-002Jul 26, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Upsher-smith LabsSORINEsotalol hydrochlorideTABLET;ORAL075500-004Apr 27, 2001AB1RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsSOTALOL HYDROCHLORIDEsotalol hydrochlorideTABLET;ORAL075238-003Jul 13, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Apotex IncSOTALOL HYDROCHLORIDEsotalol hydrochlorideTABLET;ORAL076140-004Sep 26, 2002AB1RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Covis Pharma BvBETAPACE AFsotalol hydrochlorideTABLET;ORAL021151-005Mar 14, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm IndustriesSOTALOL HYDROCHLORIDEsotalol hydrochlorideTABLET;ORAL075515-002Oct 15, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Beximco Pharms UsaSOTALOL HYDROCHLORIDEsotalol hydrochlorideTABLET;ORAL207428-002Oct 21, 2016AB1RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: sotalol hydrochloride

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2015153762► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Farmers Insurance
US Department of Justice
Cantor Fitzgerald
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: